Inforcom Technologies

Admerus Biosciences, Hyderabad joins OVIS platform for Risk Free Clinical Studies



April 02nd 2019

#Admerus Biosciences Private Limited is a CRO located in #Hyderabad, India. Admerus believes in #compliant practices following strict #regulatory routines.

Admerus has come onboard #OVIS service to ensure eligibility of #HumanVolunteers before they are hired for a study. This service offers RiskFree studies. The in-eligible volunteers are sent back and not dosed, ensuring the no health risk to the volunteer and clean reports from the studies too. This offers safety to Human Volunteers and CROs as well as accuracy guarantee to the Sponsors.

OVIS is a nation wide platform for Cross Participation Tracking platform active in 10 states and 19 cities in India. There are nearly 60 CRO facilities using this service on daily basis. OVIS has been successful in avoiding possible ADRs in over 15 Million Volunteers !

 

#OVIS #ClinicalResearch #CRO #LifeScience #ClinicalStudy #HumanVolunteers #CleanVolunteers #LowRiskStudies #RiskFreeStudies #CrossParticipation #PhaseI #PhaseIII #EarlyStage #DrugTesting #ScreeningEligibility #DosingEligibility #RiskMitigation #HealthyVolunteers #LowCostStudies #SafeStudies #ADR #SADR #AvoidADR #DrugConcentration #RealTimeStatus #USFDA #CFR11 #BA #BE #PKStudies